Cargando…

Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination

BACKGROUND: The current outbreak of novel coronavirus disease 2019 has caused a serious disease burden worldwide. Vaccines are an important factor to sustain the epidemic. Although with a relatively high-vaccination worldwide, the decay of vaccine efficacy and the arising of new variants lead us to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaohao, Liu, Ziyan, Yang, Shiting, Zhao, Zeyu, Guo, Yichao, Abudurusuli, Guzainuer, Zhao, Shanlu, Zeng, Ge, Hu, Shixiong, Luo, Kaiwei, Chen, Tianmu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836995/
https://www.ncbi.nlm.nih.gov/pubmed/36688089
http://dx.doi.org/10.1016/j.idm.2023.01.003
_version_ 1784868978926026752
author Guo, Xiaohao
Liu, Ziyan
Yang, Shiting
Zhao, Zeyu
Guo, Yichao
Abudurusuli, Guzainuer
Zhao, Shanlu
Zeng, Ge
Hu, Shixiong
Luo, Kaiwei
Chen, Tianmu
author_facet Guo, Xiaohao
Liu, Ziyan
Yang, Shiting
Zhao, Zeyu
Guo, Yichao
Abudurusuli, Guzainuer
Zhao, Shanlu
Zeng, Ge
Hu, Shixiong
Luo, Kaiwei
Chen, Tianmu
author_sort Guo, Xiaohao
collection PubMed
description BACKGROUND: The current outbreak of novel coronavirus disease 2019 has caused a serious disease burden worldwide. Vaccines are an important factor to sustain the epidemic. Although with a relatively high-vaccination worldwide, the decay of vaccine efficacy and the arising of new variants lead us to the challenge of maintaining a sufficient immune barrier to protect the population. METHOD: A case-contact tracking data in Hunan, China, is used to estimate the contact pattern of cases for scenarios including school, workspace, etc, rather than ordinary susceptible population. Based on the estimated vaccine coverage and efficacy, a multi-group vaccinated-exposed-presymptomatic-symptomatic-asymptomatic-removed model (VEFIAR) with 8 age groups, with each partitioned into 4 vaccination status groups is developed. The optimal dose-wise vaccinating strategy is optimized based on the currently estimated immunity barrier of coverage and efficacy, using the greedy algorithm that minimizes the cumulative cases, population size of hospitalization and fatality respectively in a certain future interval. Parameters of Delta and Omicron variants are used respectively in the optimization. RESULTS: The estimated contact matrices of cases showed a concentration on middle ages, and has compatible magnitudes compared to estimations from contact surveys in other studies. The VEFIAR model is numerically stable. The optimal controled vaccination strategy requires immediate vaccination on the un-vaccinated high-contact population of age 30–39 to reduce the cumulative cases, and is stable with different basic reproduction numbers ([Formula: see text]). As for minimizing hospitalization and fatality, the optimized strategy requires vaccination on the un-vaccinated of both aged 30–39 of high contact frequency and the vulnerable older. CONCLUSION: The objective of reducing transmission requires vaccination in age groups of the highest contact frequency, with more priority for un-vaccinated than un-fully or fully vaccinated. The objective of reducing total hospitalization and fatality requires not only to reduce transmission but also to protect the vulnerable older. The priority changes by vaccination progress. For any region, if the local contact pattern is available, then with the vaccination coverage, efficacy, and disease characteristics of relative risks in heterogeneous populations, the optimal dose-wise vaccinating process will be obtained and gives hints for decision-making.
format Online
Article
Text
id pubmed-9836995
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-98369952023-01-17 Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination Guo, Xiaohao Liu, Ziyan Yang, Shiting Zhao, Zeyu Guo, Yichao Abudurusuli, Guzainuer Zhao, Shanlu Zeng, Ge Hu, Shixiong Luo, Kaiwei Chen, Tianmu Infect Dis Model Article BACKGROUND: The current outbreak of novel coronavirus disease 2019 has caused a serious disease burden worldwide. Vaccines are an important factor to sustain the epidemic. Although with a relatively high-vaccination worldwide, the decay of vaccine efficacy and the arising of new variants lead us to the challenge of maintaining a sufficient immune barrier to protect the population. METHOD: A case-contact tracking data in Hunan, China, is used to estimate the contact pattern of cases for scenarios including school, workspace, etc, rather than ordinary susceptible population. Based on the estimated vaccine coverage and efficacy, a multi-group vaccinated-exposed-presymptomatic-symptomatic-asymptomatic-removed model (VEFIAR) with 8 age groups, with each partitioned into 4 vaccination status groups is developed. The optimal dose-wise vaccinating strategy is optimized based on the currently estimated immunity barrier of coverage and efficacy, using the greedy algorithm that minimizes the cumulative cases, population size of hospitalization and fatality respectively in a certain future interval. Parameters of Delta and Omicron variants are used respectively in the optimization. RESULTS: The estimated contact matrices of cases showed a concentration on middle ages, and has compatible magnitudes compared to estimations from contact surveys in other studies. The VEFIAR model is numerically stable. The optimal controled vaccination strategy requires immediate vaccination on the un-vaccinated high-contact population of age 30–39 to reduce the cumulative cases, and is stable with different basic reproduction numbers ([Formula: see text]). As for minimizing hospitalization and fatality, the optimized strategy requires vaccination on the un-vaccinated of both aged 30–39 of high contact frequency and the vulnerable older. CONCLUSION: The objective of reducing transmission requires vaccination in age groups of the highest contact frequency, with more priority for un-vaccinated than un-fully or fully vaccinated. The objective of reducing total hospitalization and fatality requires not only to reduce transmission but also to protect the vulnerable older. The priority changes by vaccination progress. For any region, if the local contact pattern is available, then with the vaccination coverage, efficacy, and disease characteristics of relative risks in heterogeneous populations, the optimal dose-wise vaccinating process will be obtained and gives hints for decision-making. KeAi Publishing 2023-01-13 /pmc/articles/PMC9836995/ /pubmed/36688089 http://dx.doi.org/10.1016/j.idm.2023.01.003 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Guo, Xiaohao
Liu, Ziyan
Yang, Shiting
Zhao, Zeyu
Guo, Yichao
Abudurusuli, Guzainuer
Zhao, Shanlu
Zeng, Ge
Hu, Shixiong
Luo, Kaiwei
Chen, Tianmu
Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title_full Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title_fullStr Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title_full_unstemmed Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title_short Contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
title_sort contact pattern, current immune barrier, and pathogen virulence determines the optimal strategy of further vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836995/
https://www.ncbi.nlm.nih.gov/pubmed/36688089
http://dx.doi.org/10.1016/j.idm.2023.01.003
work_keys_str_mv AT guoxiaohao contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT liuziyan contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT yangshiting contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT zhaozeyu contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT guoyichao contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT abudurusuliguzainuer contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT zhaoshanlu contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT zengge contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT hushixiong contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT luokaiwei contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination
AT chentianmu contactpatterncurrentimmunebarrierandpathogenvirulencedeterminestheoptimalstrategyoffurthervaccination